🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Status
Completed
Location
University Hospital Cologne
Start Date
2010-06
Trial ID
NCT01186640
Treatments Being Tested
This study is to define the safety profile and to determine the Maximal tol...
Status
Terminated
Location
Mayo Clinic
Start Date
2017-04-24
Trial ID
NCT02908451
Treatments Being Tested
This is a Phase I, randomized, double-blind, placebo-controlled clinical st...
Status
Recruiting
Location
Makerere University Walter Reed Project (MUWRP)
Start Date
2024-01-30
Trial ID
NCT06205056
Treatments Being Tested
An open label 2x2 factorial randomized trial is planned to determine the di...
Status
Unknown
Location
Sana
Start Date
2022-05-09
Trial ID
NCT05591872
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested
This phase I/II trial studies the best dose and side effects of dendritic c...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2017-08-15
Trial ID
NCT03035331
The purpose of this study is to evaluate the safety and tolerability of sin...
Status
Completed
Location
PRA Health Sciences
Start Date
2015-09-15
Trial ID
NCT02742779
A phase I dose escalation and cohort expansion study to evaluate the safety...
Status
Completed
Location
Henan Tumor Hospital
Start Date
2020-09-17
Trial ID
NCT05155722
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This randomized phase III trial studies how well gemcitabine hydrochloride ...
Status
Terminated
Location
Tennessee Valley Gynecologic Oncology
Start Date
2012-06-04
Trial ID
NCT01533207